Edition:
United States

Livzon Pharmaceutical Group Inc (000513.SZ)

000513.SZ on Shenzhen Stock Exchange

56.80CNY
2 Dec 2016
Change (% chg)

¥-1.88 (-3.20%)
Prev Close
¥58.68
Open
¥58.90
Day's High
¥58.90
Day's Low
¥56.50
Volume
4,480,655
Avg. Vol
--
52-wk High
--
52-wk Low
--

000513.SZ

Chart for 000513.SZ

About

LIVZON PHARMACEUTICAL GROUP INC. is a China-based company principally engaged in research, development, production and distribution of pharmaceutical products. The Company primarily offers western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. The Company’s... (more)

Overall

Beta: 0.70
Market Cap(Mil.): ¥22,384.23
Shares Outstanding(Mil.): 425.73
Dividend: 0.50
Yield (%): 0.86

Financials

  000513.SZ Industry Sector
P/E (TTM): 31.17 29.13 29.87
EPS (TTM): 1.86 -- --
ROI: 14.40 15.56 14.95
ROE: 14.15 16.69 16.29

BRIEF-Livzon Pharmaceutical qtrly net profit RMB205.7 mln, up 33.05 pct

* Qtrly net profit attributable to shareholders of listed company RMB 205.7 million, up 33.05%

Oct 25 2016

BRIEF-Livzon Pharmaceutical Group enters agreement with Joincare Pharmaceutical Group Industry Co

* In capital increase, co will inject rmb 40.8 million to be financed by proceeds from non-public issuance of a shares

Sep 26 2016

BRIEF-Greattown Holdings' unit plans to subscribe to Livzon Pharma's private placement

* Says unit plans to subscribe 14.9 million A-shares in Livzon Pharma's share private placement at 50.1 yuan per share

Sep 19 2016

BRIEF-Livzon Pharma's H1 net profit up 20.0 pct

* Says H1 net profit up 20.0 percent y/y at 409.1 million yuan ($61.50 million)

Aug 19 2016

BRIEF-Livzon Pharmaceutical Group issues 350 mln yuan worth super short-term debentures

* Says it issues first tranche of super short-term debentures for 2016 worth 350 million yuan, on Aug. 12, with a term of 270 days and coupon rate of 2.8 percent

Aug 14 2016

BRIEF-Livzon Pharma gets approval to issue 1.0 bln yuan commercial paper

* Says it gets approval to issue 1.0 billion yuan ($150.60 million) commercial paper

Aug 04 2016

BRIEF-Livzon Pharmaceutical sees H1 net profit up 17-25 pct

* Says it expects H1 net profit to rise 17-25 percent y/y to 398.8-426.1 million yuan ($59.52-$63.72 million)

Jul 14 2016

Earnings vs. Estimates